Skip to content

Drug interactions

Fingolimod + Thiotepa

Severity: Major

Fingolimod and Thiotepa: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Thiotepa is a myelosuppressive alkylating agent, especially at high doses used in conditioning, and fingolimod lowers lymphocyte counts. Together they may substantially increase infection risk.

What this interaction means in plain words

Fingolimod and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fingolimod belongs to Central Nervous System; Thiotepa belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic immunosuppression from marrow suppression and lymphocyte sequestration.

What to do

Consider stopping fingolimod before and during myelosuppressive thiotepa regimens. Monitor blood counts and infection signs closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Thiotepa, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Thiotepa?

MediHelp rates the interaction as major. Fingolimod and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Thiotepa is a myelosuppressive alkylating agent, especially at high doses used in conditioning, and fingolimod lowers lymphocyte counts. Together they may substantially increase infection risk.

How serious is the interaction between Fingolimod and Thiotepa?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider stopping fingolimod before and during myelosuppressive thiotepa regimens. Monitor blood counts and infection signs closely.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in